XML 25 R8.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities      
Net loss $ (5,570,446) $ (30,113,504) $ (7,446,001)
Adjustments to reconcile net loss to cash used in operating activities      
Provision/(reversal) for allowance for credit losses 425,124 2,763,188 (301,002)
Provision for inventory 277,780 483,992 184,713
Depreciation and amortization expense 55,239 1,713,096 1,385,840
Impairment of Property, plant and equipment 526,793 10,350,589
Amortization of operating and finance right-of-use assets 1,606,330 1,582,452 1,607,292
(Gain) loss on disposals of property, plant and equipment (366,708) 52,220
(Reversal) provision for warranty liability (30,725) (674,122) 42,176
Unrealized gain on short-term investment (136,638) (28,594)
Share-based compensation to consultant 9,000,000
Changes in operating assets and liabilities:      
Notes receivable 15,287 596,254
Accounts receivable (1,001,456) (288,633) 531,003
Inventories 1,172,623 906,824 1,261,751
Amounts due from related parties (69,237)
Prepaid expenses and other current assets (1,733,446) (355,151) 234,542
Deferred closing costs (231,931)
Long term accounts receivable 434,135 604,712
Accounts and notes payable 870,084 (73,656) (1,896,383)
Amounts due to related parties 37,392 (42,016) 115,330
Contract liabilities 1,793,117 91,894 (1,582,264)
Accrued expenses and other current liabilities (350,551) 1,600,448 626,965
Product warranty liability (320,295) (172,852) (1,327,270)
Lease liability 81,243
Other non-current assets (98,855)
Net cash used in operating activities (2,664,540) (2,823,640) (5,693,128)
Cash flows from investing activities      
Purchase of property, plant and equipment (160,911) (976) (548,931)
Placement of short-term investments (7,000,000)
Issuance of promissory note receivable (775,000)
Net cash used in investing activities (160,911) (7,775,976) (548,931)
Cash flows from financing activities      
Repayments of bank borrowings (706,108)
Capital injection from share capital shareholders 1,054 4,236,649
Proceeds from borrowings from related parties 1,497,472 13,897 564,887
Proceeds from borrowings from third parties 2,933,947 4,350,790 2,010,327
Repayments of borrowings to third parties (1,333,264) (526,703) (475,632)
Proceeds from loan payable with pledged assets 985,929
Repayment of loan payable with pledged assets (243,200) (246,482)
Proceeds from PIPE financing 7,000,000
Net cash provided by financing activities 3,098,155 10,595,838 6,369,570
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash (18,161) 13,197 (984,483)
Net increase (decrease) in cash, cash equivalents and restricted cash 254,543 9,419 (856,972)
Cash and cash equivalents and restricted cash, beginning of year 318,001 308,582 1,165,554
Cash and cash equivalents and restricted cash, end of year 572,544 318,001 308,582
Supplemental disclosures of cash flow information      
Cash paid for interest 22,876 60,492
Income taxes paid 2,155
Supplemental disclosures of non-cash flow information      
Payable for purchase of property, plant and equipment 315,933
Reclassification of mezzanine equity to permanent equity 9,715,267
Right-of-use assets obtained in exchange for lease liabilities 71,751
Unpaid deferred offering cost related with reverse recapitalization 69,190
Net liabilities acquired in the reverse recapitalization 3,433,249
Issuance of consultant shares 9,000,000
Settlement from discontinued operations’ receivable (323,283)
Cash and cash equivalents, beginning of the year 146,514 756  
Restricted cash, beginning of the year 171,487 307,826  
Total cash, cash equivalents and restricted cash at beginning of the year 318,001 308,582  
Cash and cash equivalents, end of the year 443,678 146,514 756
Restricted cash, end of the year 128,866 171,487 307,826
Total cash, cash equivalents and restricted cash at end of the year $ 572,544 $ 318,001 $ 308,582